ClinicalTrials.Veeva

Menu

Molecular Characterization of Cutaneous Tumors

Clalit Health Services logo

Clalit Health Services

Status

Unknown

Conditions

Squamous Cell Carcinoma
Basal Cell Carcinoma

Treatments

Genetic: Molecular testing of DNA/RNA from skin tumors, SCC/BCC

Study type

Observational

Funder types

Other

Identifiers

NCT03092830
0515-15-RMC

Details and patient eligibility

About

The objective is to find genes which are responsible for the appearance of skin tumors (sCC, BCC) and it will be the basis for prediction of the disease and response to the treatment

Full description

Prospective, 1-arm, 500 participates above 18 age with skin tumor affliction sCC and BCC type.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient that have sCC and BCC tumors
  • above 18 years old

Exclusion criteria

  • below 18 years old
  • pregnant women
  • children or person without judgment ability

Trial design

500 participants in 1 patient group

1-arm, 500 participates
Description:
Molecular testing of DNA/RNA from skin tumors, SCC/BCC
Treatment:
Genetic: Molecular testing of DNA/RNA from skin tumors, SCC/BCC

Trial contacts and locations

1

Loading...

Central trial contact

DR Asaf Olshinka, MD; DR Dean Ad EL, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems